A detailed history of Cambridge Advisors Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cambridge Advisors Inc. holds 25,387 shares of AMGN stock, worth $6.69 Million. This represents 1.83% of its overall portfolio holdings.

Number of Shares
25,387
Previous 25,273 0.45%
Holding current value
$6.69 Million
Previous $7.9 Million 3.58%
% of portfolio
1.83%
Previous 1.88%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$309.38 - $337.38 $35,269 - $38,461
114 Added 0.45%
25,387 $8.18 Million
Q2 2024

Jul 11, 2024

BUY
$262.75 - $319.31 $14,451 - $17,562
55 Added 0.22%
25,273 $7.9 Million
Q1 2024

Apr 16, 2024

SELL
$268.87 - $324.56 $19,358 - $23,368
-72 Reduced 0.28%
25,218 $7.17 Million
Q4 2023

Jan 16, 2024

SELL
$255.7 - $288.46 $9,972 - $11,249
-39 Reduced 0.15%
25,290 $7.28 Million
Q3 2023

Oct 18, 2023

BUY
$218.65 - $271.46 $6,778 - $8,415
31 Added 0.12%
25,329 $6.81 Million
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $31,497 - $37,245
-147 Reduced 0.58%
25,298 $5.62 Million
Q1 2023

Apr 13, 2023

BUY
$225.79 - $275.2 $42,222 - $51,462
187 Added 0.74%
25,445 $6.15 Million
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $12,825 - $16,296
56 Added 0.22%
25,258 $0
Q3 2022

Oct 17, 2022

SELL
$224.46 - $253.15 $74,296 - $83,792
-331 Reduced 1.3%
25,202 $5.68 Million
Q2 2022

Jul 18, 2022

SELL
$230.71 - $256.74 $12,458 - $13,863
-54 Reduced 0.21%
25,533 $6.21 Million
Q1 2022

May 05, 2022

BUY
$219.27 - $242.57 $22,146 - $24,499
101 Added 0.4%
25,587 $6.19 Million
Q4 2021

Jan 14, 2022

BUY
$198.88 - $227.6 $6,960 - $7,966
35 Added 0.14%
25,486 $5.73 Million
Q3 2021

Oct 19, 2021

BUY
$212.27 - $248.7 $25,684 - $30,092
121 Added 0.48%
25,451 $5.41 Million
Q2 2021

Jul 21, 2021

SELL
$233.58 - $259.14 $7,474 - $8,292
-32 Reduced 0.13%
25,330 $6.17 Million
Q1 2021

Apr 22, 2021

BUY
$221.91 - $258.6 $2,662 - $3,103
12 Added 0.05%
25,362 $6.31 Million
Q4 2020

Jan 25, 2021

BUY
$216.38 - $257.67 $22,070 - $26,282
102 Added 0.4%
25,350 $5.83 Million
Q3 2020

Oct 15, 2020

BUY
$234.65 - $260.95 $16,660 - $18,527
71 Added 0.28%
25,248 $6.42 Million
Q2 2020

Jul 17, 2020

BUY
$197.81 - $242.74 $19,978 - $24,516
101 Added 0.4%
25,177 $5.94 Million
Q1 2020

Apr 21, 2020

SELL
$182.24 - $241.7 $24,602 - $32,629
-135 Reduced 0.54%
25,076 $5.08 Million
Q4 2019

Jan 28, 2020

BUY
$189.21 - $243.2 $4.77 Million - $6.13 Million
25,211 New
25,211 $6.08 Million
Q3 2019

Oct 25, 2019

SELL
$174.11 - $208.62 $4.45 Million - $5.33 Million
-25,556 Closed
0 $0
Q2 2019

Jul 26, 2019

SELL
$166.7 - $195.41 $69,847 - $81,876
-419 Reduced 1.61%
25,556 $4.71 Million
Q1 2019

Apr 16, 2019

SELL
$180.87 - $203.88 $162,783 - $183,492
-900 Reduced 3.35%
25,975 $4.94 Million
Q4 2018

Jan 29, 2019

BUY
$178.4 - $208.25 $17,126 - $19,992
96 Added 0.36%
26,875 $5.23 Million
Q3 2018

Oct 24, 2018

BUY
$185.29 - $208.89 $17,046 - $19,217
92 Added 0.34%
26,779 $5.55 Million
Q2 2018

Jul 30, 2018

SELL
$166.05 - $186.51 $47,490 - $53,341
-286 Reduced 1.06%
26,687 $4.93 Million
Q1 2018

Apr 18, 2018

BUY
$169.43 - $198.0 $129,275 - $151,074
763 Added 2.91%
26,973 $4.6 Million
Q4 2017

Jan 26, 2018

SELL
$168.79 - $188.59 $125,242 - $139,933
-742 Reduced 2.75%
26,210 $4.56 Million
Q3 2017

Oct 27, 2017

BUY
$167.29 - $191.0 $4.51 Million - $5.15 Million
26,952
26,952 $5.03 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cambridge Advisors Inc. Portfolio

Follow Cambridge Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.